These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18335797)

  • 1. Newly diagnosed multiple myeloma: allograft or autograft?
    Gupta D; Kumar L
    Natl Med J India; 2007; 20(6):300-1. PubMed ID: 18335797
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft.
    Fujikawa K; Nakaseko C; Cho R; Abe D; Oda K; Tanaka H; Ohwada C; Ozawa S; Takeuchi M; Sakaida E; Shimizu N; Naito M; Nishimura M; Saito Y
    Bone Marrow Transplant; 2007 Nov; 40(10):997-9. PubMed ID: 17724437
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in transplantation therapy.
    Harousseau JL
    Oncology (Williston Park); 2004 Nov; 18(13):1614-5, 1617. PubMed ID: 15648294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of second autografts in the management of myeloma at first relapse.
    Alvares CL; Davies FE; Horton C; Patel G; Powles R; Morgan GJ
    Haematologica; 2006 Jan; 91(1):141-2. PubMed ID: 16434386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants?
    Labonté L; Iqbal T; McDiarmid S; Bence-Bruckler I; Huebsch L; Allan D
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):132-3. PubMed ID: 18158970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey].
    Inaba W; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481
    [No Abstract]   [Full Text] [Related]  

  • 9. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of allogeneic stem cell transplantation in multiple myeloma.
    Bruno B; Giaccone L; Sorasio R; Boccadoro M
    Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allografting or autografting for myeloma.
    Moreau P; Harousseau JL; Attal M
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
    Kim SJ; Kim K; Kim BS; Jo DY; Kang HJ; Kim JS; Mun YC; Kim CS; Sohn SK; Eom HS; Kwak JY; Shim H; Yoon HJ; Jin JY; Min CK; Shin H; Won JH; Lee JJ; Kwon JH; Joo YD; Do YR; Kim SH; Oh S; Suh C; Lee J; Yoon SS; Kim MK; Bang SM; Ryoo HM; Kim BS; Kim H; Kim HJ; Kim YS; Park CW; Lee GW; Shin HJ; Park SK; Park JS; Kim HY; Lee DS; Lee JH;
    Acta Haematol; 2009; 122(4):200-10. PubMed ID: 19887776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma.
    Stocchi R; Damiani D; Masolini P; Michelutti A; Baccarani M; Tosi P; Fanin R
    Haematologica; 2004 Apr; 89(4):ELT02. PubMed ID: 15075115
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Kuendgen A; Fenk R; Bruns I; Dommach M; Schutte A; Engers R; Hünerlitürkoglu A; Haas R; Kobbe G
    Bone Marrow Transplant; 2006 Jul; 38(1):69-70. PubMed ID: 16715114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical analysis of therapeutic impact and prognosis of autologous peripheral blood stem cell transplantation in multiple myeloma].
    Qu XY; Chen LJ; Miao KR; Zhang R; Lu RN; Liu P; Qian SX; Lu H; Qiu HX; Xu W; Wu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):352-4. PubMed ID: 23668212
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell collection in multiple myeloma: a retrospective analysis of 6 years leukapheresis activity in 109 patients treated at the Istituto Nazionale dei Tumori of Milan.
    Coluccia P; Montefusco V; Tunesi S; Avella M; Bompadre A; Longoni P; Milanesi M; De Carli A; Ravagnani F
    J Clin Apher; 2009; 24(4):134-40. PubMed ID: 19591198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining better quality of life with reduced costs in patients with multiple myeloma.
    Haematologica; 2002 Nov; 87(11):1125. PubMed ID: 12414339
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.